China’s first mRNA Covid-19 vaccine approved for use in Indonesia

By Zhuang Pinghui

Indonesia has become the first country to approve a Chinese home-grown mRNA Covid-19 vaccine for emergency use.

The Indonesian Food and Drugs Agency on Thursday approved AWcorna for primary and booster use by people aged 18 years old and above, according to a report in China’s Communist Party mouthpiece People’s Daily.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
China , Vaccine , Indonesia

Next In Aseanplus News
Laos, Republic of Korea lift ties to comprehensive partnership
'Hero' who disarmed Bondi gunman recovers in hospital as donations pour in
Australian PM Albanese visits Bondi Beach hero in hospital
Indonesian police seize thousands of timber products from illegal logging in Riau
Hand, foot and mouth disease cases on the rise in Vietnam’s Ho Chi Minh City
No ‘Merry Christmas’ for flood control mess culprits, Philippines' Palace maintains
Surplus budget helps Sabah's growth, but 40% revenue share will be a bigger boost, says KDM rep
Singaporean woman fined for passing gin to driver after car crash to interfere with breathalyser test
EC holds meeting to discuss Kinabatangan, Lamag by-elections
Mesra Malaysia training programme rolling out nationwide to boost VM2026

Trending in AseanPlus

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.